| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |